Semax

Product Overview

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH), specifically ACTH (4–10), with structural modifications designed to improve peptide stability.

Semax has gained attention in scientific research for its potential interactions with neurological signalling pathways, neurotrophic factors and cellular processes associated with the central nervous system.

Its unique molecular structure makes it a compound of interest in laboratory investigations exploring neurobiology, cognitive processes and neuronal signalling.

Manufacturing

Semax can be synthesised using advanced solid-phase peptide synthesis (SPPS) techniques to achieve precise molecular structure, purity and consistency.

Each batch undergoes independent third-party testing to assess peptide identity and purity, with laboratory results.

The peptide is carefully handled and packaged to help maintain product integrity throughout storage and transport.

Research Applications

Semax is studied in scientific research exploring:

• Neurological Signalling: Investigation of molecular pathways involved in communication between neurons and central nervous system activity.

• Cognitive Research: Examination of biological mechanisms associated with learning, memory and information processing.

• Neurotrophic Factors: Research into signalling pathways associated with brain-derived neurotrophic factor (BDNF) and neuronal function.

• Cellular Protection: Preclinical investigation of neuronal responses to oxidative stress and other cellular challenges.

• Neuroplasticity: Studies exploring neuronal adaptation, synaptic signalling and mechanisms associated with nervous system plasticity.

Disclaimer

For research purposes only. Not for human consumption.